U.S. Drug Administration approves emergency use of Pfizer’s new crown vaccine for 5 to 11-year-olds
Home> News> e Company
The U.S. Drug Administration approves Pfizer’s new crown vaccine for emergency use in 5 to 11-year-olds
2021-10-30 12:25
Source: Securities Times·e Company
Author: Peng Fei
Securities Times·e Company
Peng Fei
2021-10-30 12:25
Securities Times e Company News, the US Food and Drug Administration issued a statement on the 29th, approving the emergency use of the new crown vaccine jointly developed by Pfizer and German Biotech for the 5 to 11-year-olds. The statement said that the approval of this authorization was based on a “thorough and transparent evaluation” of existing data, including expert opinions from the Independent Advisory Committee of the US Drug Administration. Five to 11-year-old groups receive two doses of Pfizer vaccine, 21 days apart, but the inoculation dose is 10 micrograms per dose, which is one-third of the applicable dose for people aged 12 and above.
Disclaimer: The Securities Times strives to be truthful and accurate. The content mentioned in the article is for reference only and does not constitute substantive investment advice. The operation is at your own risk accordingly.
3821391
The U.S. Drug Administration approves Pfizer’s new crown vaccine for emergency use in 5 to 11-year-olds
6885
e company
news
1445
Peng Fei
2021-10-30